Foundry Partners, LLC - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 356 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.4%.

Quarter-by-quarter ownership
Foundry Partners, LLC ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$4,038,000
-48.2%
35,135
-29.6%
0.33%
-54.0%
Q3 2014$7,794,000
+23.2%
49,885
-2.7%
0.72%
+23.2%
Q2 2014$6,324,000
+1485.0%
51,265
+1229.8%
0.59%
+1483.8%
Q1 2014$399,0003,8550.04%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Consonance Capital Management LP 467,943$30,954,00011.01%
TANG CAPITAL MANAGEMENT LLC 300,000$19,845,0007.82%
OAK RIDGE INVESTMENTS LLC 1,382,895$91,478,0002.87%
SECTOR GAMMA AS 147,001$9,724,0002.84%
Credo Capital Management, LLC 38,869$2,571,0001.98%
Cardinal Capital Management 48,226$3,190,0001.89%
ZEVENBERGEN CAPITAL INVESTMENTS LLC 626,800$41,463,0001.68%
HERNDON CAPITAL MANAGEMENT LLC 1,284,472$84,967,823,0001.27%
CATAPULT CAPITAL MANAGEMENT LLC 45,000$2,977,0001.24%
Pier Capital, LLC 108,556$7,181,0001.10%
View complete list of SALIX PHARMACEUTICALS INC shareholders